Authors:
Miceli, JJ
Wilner, KD
Hansen, RA
Johnson, AC
Apseloff, G
Gerber, N
Citation: Jj. Miceli et al., Single- and multiple-dose pharmacokinetics of ziprasidone under non-fasting conditions in healthy male volunteers, BR J CL PH, 49, 2000, pp. 5S-13S
Authors:
Wilner, KD
Tensfeldt, TG
Baris, B
Smolarek, TA
Turncliff, RZ
Colburn, WA
Hansen, RA
Citation: Kd. Wilner et al., Single- and multiple-dose pharmacokinetics of ziprasidone in healthy youngand elderly volunteers, BR J CL PH, 49, 2000, pp. 15S-20S
Authors:
Everson, G
Lasseter, KC
Anderson, KE
Bauer, LA
Carithens, RL
Wilner, KD
Johnson, A
Anziano, RJ
Smolarek, TA
Turncliff, RZ
Citation: G. Everson et al., The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function, BR J CL PH, 49, 2000, pp. 21S-26S
Authors:
Wilner, KD
Hansen, RA
Folger, CJ
Geoffroy, P
Citation: Kd. Wilner et al., The pharmacokinetics of ziprasidone in healthy volunteers treated with cimetidine or antacid, BR J CL PH, 49, 2000, pp. 57S-60S
Authors:
Apseloff, G
Mullet, D
Wilner, KD
Anziano, RJ
Tensfeldt, TG
Pelletier, SM
Gerber, N
Citation: G. Apseloff et al., The effects of ziprasidone on steady-state lithium levels and renal clearance of lithium, BR J CL PH, 49, 2000, pp. 61S-64S